User menu

ZIRCON: Pharmacokinetics, Safety, and Efficacy of Ombitasvir/Paritaprevir/Ritonavir ± THU-251 Dasabuvir ± Ribavirin in Adolescents With Genotype 1 or 4 Hepatitis C Virus Infection

Bibliographic reference Leung, Daniel ; Yao, Betty ; Gonzalez-Peralta, Regino ; Jonas, Maureen ; Lobritto, Steven ; et. al. ZIRCON: Pharmacokinetics, Safety, and Efficacy of Ombitasvir/Paritaprevir/Ritonavir ± THU-251 Dasabuvir ± Ribavirin in Adolescents With Genotype 1 or 4 Hepatitis C Virus Infection .The International Liver Congress (EASL) (Amsterdam, the Netherlands, du 19/04/2017 au 23/04/2017).
Permanent URL http://hdl.handle.net/2078.1/184191